Rejuvenation Technologies Inc.
YC S18San Francisco, US · Founded 2016 · 2 employees · 1 known investors
Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.
Founders & leadership· Y Combinator alumni (S18)
Glenn MarkovinFounder
John RamunasinFounder
<
<UNKNOWN>MBBS MRCP FRACP MD FQA, Clinical Professor at U. of Queensland